ECSP982656A - CERTAIN ENDOTHELINE ANTAGONISTS OF BENZOTIAZINE DIOXIDE AND PROCESSES FOR ITS PREPARATION - Google Patents

CERTAIN ENDOTHELINE ANTAGONISTS OF BENZOTIAZINE DIOXIDE AND PROCESSES FOR ITS PREPARATION

Info

Publication number
ECSP982656A
ECSP982656A ECSP982656A ECSP982656A EC SP982656 A ECSP982656 A EC SP982656A EC SP982656 A ECSP982656 A EC SP982656A EC SP982656 A ECSP982656 A EC SP982656A
Authority
EC
Ecuador
Prior art keywords
benzotiazine
dioxide
processes
preparation
certain
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jeremy John Edmunds
Joseph Thomas Repine
Xue-Min Cheng
Chitase Lee
Amy Mae Bunker
Annete Marian Doherty
Gerald David Kanter
Richard William Skeean
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982656 priority Critical patent/ECSP982656A/en
Publication of ECSP982656A publication Critical patent/ECSP982656A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención es una serie de dióxidos de benzotiazina o una sal farmacéuticamente aceptable de ellos, que son potentes antagonistas de endotelina A con profunda actividad en tubo de ensayo y sintesis mejoradas para la fórmula I (gráfico), los compuestos son útiles en el tratamiento de niveles elevados de endotelina, hipertensión esencial renovascular maligna y pulmonar, infarto cerebral, isquemia cerebral, insuficiencia cardiaca congestiva y hemorragia subaracnoide.The invention is a series of benzothiazine dioxides or a pharmaceutically acceptable salt thereof, which are potent endothelin A antagonists with profound test tube activity and improved syntheses for formula I (graph), the compounds are useful in the treatment of elevated endothelin levels, essential malignant and pulmonary renovascular hypertension, cerebral infarction, cerebral ischemia, congestive heart failure, and subarachnoid hemorrhage.

ECSP982656 1998-09-04 1998-09-04 CERTAIN ENDOTHELINE ANTAGONISTS OF BENZOTIAZINE DIOXIDE AND PROCESSES FOR ITS PREPARATION ECSP982656A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982656 ECSP982656A (en) 1998-09-04 1998-09-04 CERTAIN ENDOTHELINE ANTAGONISTS OF BENZOTIAZINE DIOXIDE AND PROCESSES FOR ITS PREPARATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982656 ECSP982656A (en) 1998-09-04 1998-09-04 CERTAIN ENDOTHELINE ANTAGONISTS OF BENZOTIAZINE DIOXIDE AND PROCESSES FOR ITS PREPARATION

Publications (1)

Publication Number Publication Date
ECSP982656A true ECSP982656A (en) 1999-04-16

Family

ID=42043576

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982656 ECSP982656A (en) 1998-09-04 1998-09-04 CERTAIN ENDOTHELINE ANTAGONISTS OF BENZOTIAZINE DIOXIDE AND PROCESSES FOR ITS PREPARATION

Country Status (1)

Country Link
EC (1) ECSP982656A (en)

Similar Documents

Publication Publication Date Title
PA8561901A1 (en) CIS-IMIDAZOLINS
NO973822D0 (en) Benzothiazine dioxides as endothelin antagonists
CY1108744T1 (en) 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine-3-yl-piperidines as CGRP antagonists
FI964317A0 (en) Factor Xa inhibitors
NO921609D0 (en) SULPHONAMIDS AND THEIR MEDICAL USE
CY1113487T1 (en) NEW MANDELIC ACID PRODUCERS AND THEIR USE AS THROBS
UY27255A1 (en) DERIVATIVES OF MERCAPTOACETILAMIDE, PROCEDURE FOR PREPARATION AND USE
CY1105519T1 (en) PYRROLIDINE DERIVATIVES USEFUL AS BAX PROTEIN INHIBITORS
EA200200742A1 (en) 1,2-DIARYLBENZYMIDAZOLEY FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF MICROGLY
EA200300392A1 (en) Derivatives of piperazine with a bridge connection
ECSP982656A (en) CERTAIN ENDOTHELINE ANTAGONISTS OF BENZOTIAZINE DIOXIDE AND PROCESSES FOR ITS PREPARATION
ECSP034487A (en) USE OF A COMBINATION OF SALMETEROL AND FLUTICASONA
BR9812431A (en) Some benzothiazine dioxide endothelin antagonists and processes for their preparation
NO20013832L (en) Piperidine and piperazine derivatives as inhibitors of Abeta fibril formation
DE50101861D1 (en) TOCOTRIENOLCHINONE CYCLIZING PRODUCTS WITH ANTIHYPERCHOLESTERINE EFFECT
NO20002408D0 (en) 5-HT1F antagonists
EA200400438A1 (en) THE USE OF IRBESARTAN FOR THE PRODUCTION OF DRUGS WHICH ARE SUITABLE FOR THE PREVENTION OR TREATMENT OF PULMONARY HYPERTENSION
PT1276495E (en) USING RECOMBINANT PULMONARY TENSIONS FOR THE EARLY TREATMENT OF ACUTE PULMONARY DISEASES
UY27523A1 (en) TETRA-, PENTA-, HEXA-Y HEPTAPEPTIDES WITH ANTIANGIOGEN ACTIVITY
CY1105432T1 (en) USES OF THALIPORFIN OR ITS DERIVATIVES IN THE TREATMENT OF HEART DISEASE AND PREPARATION THEREOF
ECSP045295A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE 2- (4-ETOXI-PHENYL) -3- (4-METHANOSULPHONYL-PHENYL) -PIRAZOLO'1,5-BIPIRIDACINA IN NANOPARTICULATED FORM
BR0212122A (en) Peptide Arginals and Methods for Treatment of Disseminated Intravascular Coagulation
TH69990A (en) Cis-2,4,5-Triaryyl-Imidazoline
ITSV20010001U4 (en) SEE INVENTION No. 16 OF 1998
ATE466026T1 (en) DERIVATIVES OF GLP-1 AND EXENDIN WITH EXTENDED DURATION PROFILE